William D. Barbo, Corporate Executive VP & CCO at CHARLES RIVER LABORATORIES INTERNATIONAL INC (CRL), sold 11,958 shares at $140.58 ($1.7M) on 2019-02-27, disclosed to the SEC on 2019-03-01.
Open-market sale of $1.7M CRL by Corporate Executive VP & CCO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $140.58 | 1,000 | $141K | 8.4% |
| 2 | $140.59 | 11 | $2K | 0.1% |
| 3 | $140.60 | 200 | $28K | 1.7% |
| 4 | $140.60 | 11 | $2K | 0.1% |
| 5 | $140.62 | 400 | $56K | 3.3% |
| 6 | $140.62 | 101 |
| $14K |
| 0.8% |
| 7 | $140.63 | 200 | $28K | 1.7% |
| 8 | $140.64 | 5 | $703 | 0.0% |
| 9 | $140.65 | 1,300 | $183K | 10.9% |
| 10 | $140.66 | 800 | $113K | 6.7% |
| 11 | $140.67 | 1,100 | $155K | 9.2% |
| 12 | $140.68 | 100 | $14K | 0.8% |
| 13 | $140.68 | 100 | $14K | 0.8% |
| 14 | $140.68 | 406 | $57K | 3.4% |
| 15 | $140.69 | 515 | $72K | 4.3% |
| 16 | $140.69 | 59 | $8K | 0.5% |
| 17 | $140.69 | 515 | $72K | 4.3% |
| 18 | $140.70 | 539 | $76K | 4.5% |
| 19 | $140.71 | 500 | $70K | 4.2% |
| 20 | $140.72 | 530 | $75K | 4.4% |
| 21 | $140.73 | 300 | $42K | 2.5% |
| 22 | $140.74 | 100 | $14K | 0.8% |
| 23 | $140.75 | 404 | $57K | 3.4% |
| 24 | $140.76 | 400 | $56K | 3.3% |
| 25 | $140.77 | 300 | $42K | 2.5% |
| 26 | $140.78 | 500 | $70K | 4.2% |
| 27 | $140.78 | 100 | $14K | 0.8% |
| 28 | $140.78 | 230 | $32K | 1.9% |
| 29 | $140.78 | 100 | $14K | 0.8% |
| 30 | $140.79 | 800 | $113K | 6.7% |
| 31 | $140.79 | 100 | $14K | 0.8% |
| 32 | $140.80 | 100 | $14K | 0.8% |
| 33 | $140.81 | 112 | $16K | 0.9% |
| 34 | $140.81 | 10 | $1K | 0.1% |
| 35 | $140.82 | 10 | $1K | 0.1% |
| Total | $140.69 avg | 11,958 | $1.7M | 100% |
| Filing → |
| CRL | SELL | 2022-12-06 | $1.3M | — | Filing → |
| CRL | SELL | 2021-08-10 | $9.7M | — | Filing → |
| CRL | SELL | 2021-03-02 | $2.7M | — | Filing → |